Advertisement

Utility of Cardiac Ultrasound Imaging in Oncology, a Case Based Illustration

  • Jose A. Banchs
Chapter

Abstract

Cardiac Ultrasound imaging (Echocardiogram) is an integral modality for the investigation of patients undergoing chemotherapy. In this chapter we briefly discuss the evolution and provide case based illustrations to exemplify the use of this modality.

Keywords

Echocardiogram Chemotherapy Cardiotoxicity 

References

  1. 1.
    Kobayashi T, Nakayama R, Takatani O, Kimura K. Positive chronotropic and inotropic actions of new antitumor agent adriamycin and its cardiotoxicity–its special references to myocardial contractile force and the change of the transmembrane action potential. Jpn Circ J. 1972;36:259–65.PubMedGoogle Scholar
  2. 2.
    Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973;32:302–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Rinehart JJ, Lewis RP, Balcerzak SP. Adriamycin cardiotoxicity in man. Ann Intern Med. 1974;81:475–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Greco FA, Brereton HD, Rodbard D. Noninvasive monitoring of adriamycin cardiotoxicity by “Sphygmo-Recording” of the pulse wave delay (QKd interval). Cancer Treat Rep. 1976;60:1239–45.PubMedGoogle Scholar
  5. 5.
    Ramos A, Meyer RA, Korfhagen J, Wong KY, Kaplan S. Echocardiographic evaluation of adriamycin cardiotoxicity in children. Cancer Treat Rep. 1976;60:1281–4.PubMedGoogle Scholar
  6. 6.
    Alcan KE, Robeson W, Graham MC, Palestro C, Oliver FH, Benua RS. Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysis. Clin Nucl Med. 1985;10:160–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Lenzhofer R, Dudczak R, Gumhold G, Graninger W, Moser K, Spitzy KH. Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy. J Cancer Res Clin Oncol. 1983;106:136–42.CrossRefPubMedGoogle Scholar
  8. 8.
    McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J. 1983;106:1048–56.CrossRefPubMedGoogle Scholar
  9. 9.
    Pauwels EK, Horning SJ, Goris ML. Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity. Radiother Oncol. 1983;1:83–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Senior R, Soman P, Khattar RS, Lahiri A. Improved endocardial visualization with second harmonic imaging compared with fundamental two-dimensional echocardiographic imaging. Am Heart J. 1999;138:163–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol. 1998;32:1426–32.CrossRefPubMedGoogle Scholar
  12. 12.
    Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, et al. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol. 2000;35:477–84.CrossRefPubMedGoogle Scholar
  13. 13.
    Walker J, Bhullar N, Fallah-Rad N, Lytwyn M, Golian M, Fang T, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28:3429–36.CrossRefPubMedGoogle Scholar
  14. 14.
    Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol. 2007;25:3525–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.CrossRefPubMedGoogle Scholar
  16. 16.
    Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24:1268–75.e1.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J. 2009;158:294–301.CrossRefPubMedGoogle Scholar
  18. 18.
    Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57:2263–70.CrossRefPubMedGoogle Scholar
  19. 19.
    Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107:1375–80.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63:2751–68.CrossRefPubMedGoogle Scholar
  21. 21.
    Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911–39.CrossRefPubMedGoogle Scholar
  22. 22.
    Marwick TH. Consistency of myocardial deformation imaging between vendors. Eur J Echocardiogr. 2010;11(5):414–6.  https://doi.org/10.1093/ejechocard/jeq006. Epub 17 Feb 2010.CrossRefPubMedGoogle Scholar
  23. 23.
    Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61(1):77–84.  https://doi.org/10.1016/j.jacc.2012.09.035. Epub 28 Nov 2012.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of CardiologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations